Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus Infection
Fengqi Li, Hanqing Zhu, Rui Sun, et al.
Journal of Virology (2011) Vol. 86, Iss. 4, pp. 2251-2258
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

The host immune response in respiratory virus infection: balancing virus clearance and immunopathology
A. H. Newton, Amber Cardani, Thomas J. Braciale
Seminars in Immunopathology (2016) Vol. 38, Iss. 4, pp. 471-482
Open Access | Times Cited: 443
Natural killer cells in liver disease
Zhigang Tian, Yongyan Chen, Bin Gao
Hepatology (2012) Vol. 57, Iss. 4, pp. 1654-1662
Open Access | Times Cited: 265
Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
Hongjing Gu, Zhengde Xie, Tieling Li, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 251
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Elisabeth A. van Erp, Willem Luytjes, Gerben Ferwerda, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 239
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Yiyue Ge, Tingzhong Tian, Suling Huang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 185
Natural Killer Cell Dysfunction and Its Role in COVID-19
Charmaine van Eeden, Lamia Khan, Mohammed Osman, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6351-6351
Open Access | Times Cited: 166
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
Marisa Market, Leonard Angka, Andre B. Martel, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 145
Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection
Yohsuke Tomosada, Eriko Chiba, Hortensia Zelaya, et al.
BMC Immunology (2013) Vol. 14, Iss. 1
Open Access | Times Cited: 153
Roles of natural killer cells in antiviral immunity
Stephen N. Waggoner, Seth D. Reighard, Ivayla E. Gyurova, et al.
Current Opinion in Virology (2015) Vol. 16, pp. 15-23
Open Access | Times Cited: 147
NK cells and interferons
Rossella Paolini, Giovanni Bernardini, Rosa Molfetta, et al.
Cytokine & Growth Factor Reviews (2014) Vol. 26, Iss. 2, pp. 113-120
Closed Access | Times Cited: 132
Natural Killer Cells in the Lungs
Jingjing Cong, Haiming Wei
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 109
The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
Dawei Sun, Dong Zhang, Run-hui Tian, et al.
Clinica Chimica Acta (2020) Vol. 508, pp. 122-129
Open Access | Times Cited: 91
Viral Infection of Human Natural Killer Cells
Elisabeth A. van Erp, Mirjam van Kampen, Puck B. van Kasteren, et al.
Viruses (2019) Vol. 11, Iss. 3, pp. 243-243
Open Access | Times Cited: 80
Immunopathology of RSV: An Updated Review
Harrison C. Bergeron, Ralph A. Tripp
Viruses (2021) Vol. 13, Iss. 12, pp. 2478-2478
Open Access | Times Cited: 69
T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
Olatz Zenarruzabeitia, Gabirel Astarloa-Pando, Iñigo Terrén, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
Host Responses to Respiratory Syncytial Virus Infection
Ayse Agac, Sophie M. Kolbe, Martin Ludlow, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1999-1999
Open Access | Times Cited: 23
Pulmonary delivery of silver nanoparticles prevents influenza infection by recruiting and activating lymphoid cells.
Lydie Martín-Faivre, Lisa K. Prince, Clémentine Cornu, et al.
Biomaterials (2024) Vol. 312, pp. 122721-122721
Closed Access | Times Cited: 8
Lung natural killer cells in mice: phenotype and response to respiratory infection
Jian Wang, Fengqi Li, Meijuan Zheng, et al.
Immunology (2012) Vol. 137, Iss. 1, pp. 37-47
Open Access | Times Cited: 90
Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection
Eriko Chiba, Yohsuke Tomosada, María Guadalupe Vizoso-Pinto, et al.
International Immunopharmacology (2013) Vol. 17, Iss. 2, pp. 373-382
Open Access | Times Cited: 83
NK cells in immunotolerant organs
Haoyu Sun, Cheng Sun, Zhigang Tian, et al.
Cellular and Molecular Immunology (2013) Vol. 10, Iss. 3, pp. 202-212
Open Access | Times Cited: 73
Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection
Lena Glaser, Patricia Coulter, Michael D. Shields, et al.
Pathogens (2019) Vol. 8, Iss. 3, pp. 106-106
Open Access | Times Cited: 66
Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus
Stephanie Ascough, Suzanna Paterson, Christopher Chiu
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 61
Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells
Marlena Scharenberg, Sindhu Vangeti, Eliisa Kekäläinen, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 58
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection
Roberto Littera, Luchino Chessa, Silvia Deidda, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255608-e0255608
Open Access | Times Cited: 47
Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection
Georges Abboud, Vikas Tahiliani, Pritesh Desai, et al.
Journal of Virology (2015) Vol. 90, Iss. 1, pp. 129-141
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top